Metraipolis › archive › dc_2d7fcaae578a

Finn Waagstein and the paradigm shift in the treatment of heart failure with β-adrenergic receptor antagonists ('β-blockers') — Europe PMC PMID:41081790

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41081790
DOI
10.1007/s00210-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-09T09:02:03.855Z
SHA-256 of the archived text
28cef84e02279bc5ae0adbb946cf9bb65d626a838ffa46a1871748b07fe87507
Stable URL of this page
https://metraipolis.com/documento/dc_2d7fcaae578a

How to cite

Finn Waagstein and the paradigm shift in the treatment of heart failure with β-adrenergic receptor antagonists ('β-blockers') — Europe PMC PMID:41081790 — Europe PMC (en), https://europepmc.org/article/MED/41081790 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2d7fcaae578a (Metraipolis archive dc_2d7fcaae578a, sha256 28cef84e02279bc5ae0adbb946cf9bb65d626a838ffa46a1871748b07fe87507)
BibTeX
@misc{dc2d7fcaae578a,
  title = {Finn Waagstein and the paradigm shift in the treatment of heart failure with β-adrenergic receptor antagonists ('β-blockers') — Europe PMC PMID:41081790},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41081790},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2d7fcaae578a; sha256 28cef84e02279bc5ae0adbb946cf9bb65d626a838ffa46a1871748b07fe87507},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41081790. Agents can read the archived copy with the MCP tool read_document.